Top compounds associated with response to USP17L30


Feature Type Standardized
Nominal ANOVA
mRNA ML311 CTRPv2 pan-cancer AAC 0.029 0.4
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.4
mRNA L-685458 CTRPv2 pan-cancer AAC -0.033 0.4
mRNA 5-FU CTRPv2 pan-cancer AAC 0.03 0.4
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.045 0.4
mRNA PI-103 CTRPv2 pan-cancer AAC 0.03 0.4
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.032 0.4
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC 0.059 0.4
mRNA rigosertib CTRPv2 pan-cancer AAC 0.028 0.4
mRNA myriocin CTRPv2 pan-cancer AAC -0.07 0.4
Download CSV